Company Name: |
Pharmacodia (Beijing) Co.,Ltd
|
Tel: |
+86-400-851-9921 |
Email: |
sales@pharmacodia.com |
Products Intro: |
Product Name:FQI1 CAS:599151-35-6 Package:10Mg-100g
|
Company Name: |
Lynnchem
|
Tel: |
86-(0)29-85992781 17792393971 |
Email: |
info@lynnchem.com |
Products Intro: |
Product Name:8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one CAS:599151-35-6 Purity:95% Package:1mg;5mg
|
Company Name: |
Novachemistry
|
Tel: |
44-20819178-90 02081917890 |
Email: |
info@novachemistry.com |
Products Intro: |
Product Name:FQI1 CAS:599151-35-6 Purity:95% Package:1mg;5mg
|
|
| 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one Basic information |
Product Name: | 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one | Synonyms: | 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one;FQI1;FQI1
(FQI 1);8-(2-ethoxyphenyl)-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]quinolin-6-one;FQI1 >=98% (HPLC);1,3-Dioxolo[4,5-g]quinolin-6(5H)-one, 8-(2-ethoxyphenyl)-7,8-dihydro- | CAS: | 599151-35-6 | MF: | C18H17NO4 | MW: | 311.33 | EINECS: | | Product Categories: | | Mol File: | 599151-35-6.mol | |
| 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one Chemical Properties |
Boiling point | 463.6±45.0 °C(Predicted) | density | 1.272±0.06 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | DMSO: soluble10mg/mL (clear solution) | form | powder | pka | 13.36±0.40(Predicted) | color | white to beige | Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
Hazard Codes | T,N | Risk Statements | 25-50 | Safety Statements | 45-61 | RIDADR | UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., HI: all | WGK Germany | 3 |
| 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one Usage And Synthesis |
Description | FQI1 (599151-35-6) is an inhibitor of transcription factor LSF specifically targeting its DNA binding and corresponding transcriptional activity (IC50=2.1 μM). Rapidly induces apoptosis in an aggressive hepatocellular carcinoma (HCC) cell line and dramatically inhibits tumor growth in a mouse xenograft model with no general tissue cytotoxicity.1,2?In human HCC cells, FQI1 induced mitotic arrest with an accompanying increase in cyclin B1.3?Blocks LSF-stimulated activation of DNA methyltransferase 1.4?Cell permeable. | References | 1) Grant?et al.?(2012),?Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma; Proc. Natl. Acad. Sci. USA,?109?4503
2) Santhekadur?et al. (2012),?The transcription factor LSF: a novel oncogene for hepatocellular carcinoma; Am. J. Cancer Res.,?2?269
3) Raiasekaran?et al. (2015),?Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model;?Oncotarget?6?26266
4) Chin?et al.?(2016),?Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression; Oncotarget,?7?83627 |
| 8-(2-Ethoxyphenyl)-7,8-dihydro-1,3-Dioxolo[4,5-g]quinolin-6(5H)-one Preparation Products And Raw materials |
|